Global Rivaroxaban Market by Manufacturers, Regions, Type and Application, Forecast to 2023
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8â€“ 12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
Sample Copy of This Report: https://marketreportscenter.com/request-sample/595390 Scope of the Report: This report focuses on the Rivaroxaban in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The global average price of Rivaroxaban is in the decreasing trend, from 5.62 USD/Unit in 2011 to 5.34 USD/Unit in 2015. With the situation of global economy, prices will be in slowly decreasing trend in the following five years. Bayer is the only supplier of Rivaroxaban enjoying production market share100% in 2015 and it will still in this situation until 2023. The worldwide market for Rivaroxaban is expected to grow at a CAGR of roughly 9.4% over the next five years, will reach 10100 million US$ in 2023, from 5860 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers Bayer J&J Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers 2.5 mg 10 mg 15 mg 20 mg Market Segment by Applications, can be divided into Acute Coronary Syndrome (ACS) Venous Thromboembolism (VTE)
Full report with Table of Content: https://marketreportscenter.com/reports/595390/globalrivaroxaban-market-by-manufacturers-regions-type-and-application-forecast-to-2023 There are 15 Chapters to deeply display the global Rivaroxaban market. Chapter 1, to describe Rivaroxaban Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Rivaroxaban, with sales, revenue, and price of Rivaroxaban, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Rivaroxaban, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions; Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018; Chapter 12, Rivaroxaban market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023; Chapter 13, 14 and 15, to describe Rivaroxaban sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
â€Ś Request Discount: https://marketreportscenter.com/request-discount/595390
About Market Reports Center; Market Reports Center is an e-commerce platform obliging the needs of knowledge workers, experts, professionals who are subject to market research information for their work, or to make strategic business decisions. We are dedicated to create a comprehensive offering of market research which is accurate, credible and affordable.
Connect for more details: Sam Collins Market Reports Center 1-646-883-3044 (US) Email: email@example.com Website: https://marketreportscenter.com